Image source: The Motley Fool. 28, 2026 CALL PARTICIPANTS Head of Investor Relations-David Nikodem Chief Executive Officer-Andrew Obenshain Chief Medical Officer and President of R&D-Dr.
Read the original report for the complete account of this story.